Join Donna Ryan, MD, Deborah Horn, DO, and Matthew Budoff, MD, for a conversation about the evolution of obesity medicine and associated clinical practice guidelines.
Join Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Deborah Horn, DO, Associate Professor at the University of Texas Center McGovern Medical School and Medical Director of the Center for Obesity Medicine and Metabolic Performance in Houston, Texas; and Matthew Budoff, MD, Professor of Medicine In-Residence at the David Geffen School of Medicine and Endowed Chair of Preventive Cardiology at the Lundquist Institute for Biomedical Innovation at Harbor- UCLA Medical Center in Los Angeles, California, for a conversation about the evolution of anti-obesity medicine and associated clinical practice guidelines. The panel will also discuss clinical data from a trial that evaluated a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for chronic weight management in adult patients with obesity or overweight with a weight-related comorbidity. Data on the effects of the GLP-1 RA on cardiometabolic risk factors, as observed in this trial, will also be presented. Lastly, the panel will review data from a cardiovascular outcomes trial which assessed the effect of the GLP-1 RA on reducing the risk of major adverse cardiovascular events (MACE) in patients with obesity or overweight and established cardiovascular disease.
Please see Prescribing Information, including boxed warning.
This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.
The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast.
Faculty Presenters:
Donna Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA
Deborah Bade Horn, DO MPH MFOMA Medical Director
University of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP)
Associate Professor
University of Texas McGovern Medical School, Department of Surgery
Program Director
UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance
Diplomate
American Board of Obesity Medicine Houston, TX
Matthew Jay Budoff, MD
Professor of Medicine
University of California Los Angeles Endowed Chair of Preventative Cardiology Lundquist Institute
Torrance, CA